Burden of liver diseases in the world
- PMID: 30266282
- DOI: 10.1016/j.jhep.2018.09.014
Burden of liver diseases in the world
Abstract
Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due to complications of cirrhosis and 1million due to viral hepatitis and hepatocellular carcinoma. Cirrhosis is currently the 11th most common cause of death globally and liver cancer is the 16th leading cause of death; combined, they account for 3.5% of all deaths worldwide. Cirrhosis is within the top 20 causes of disability-adjusted life years and years of life lost, accounting for 1.6% and 2.1% of the worldwide burden. About 2 billion people consume alcohol worldwide and upwards of 75 million are diagnosed with alcohol-use disorders and are at risk of alcohol-associated liver disease. Approximately 2 billion adults are obese or overweight and over 400 million have diabetes; both of which are risk factors for non-alcoholic fatty liver disease and hepatocellular carcinoma. The global prevalence of viral hepatitis remains high, while drug-induced liver injury continues to increase as a major cause of acute hepatitis. Liver transplantation is the second most common solid organ transplantation, yet less than 10% of global transplantation needs are met at current rates. Though these numbers are sobering, they highlight an important opportunity to improve public health given that most causes of liver diseases are preventable.
Keywords: Burden; Chronic liver disease.
Copyright © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Comment in
-
Alcohol-associated liver disease, not hepatitis B, is the major cause of cirrhosis in Asia.J Hepatol. 2019 May;70(5):1031-1032. doi: 10.1016/j.jhep.2019.01.003. Epub 2019 Feb 16. J Hepatol. 2019. PMID: 30782425 No abstract available.
-
Reply to: "Alcohol-associated liver disease, not hepatitis B, is the major cause of cirrhosis in Asia".J Hepatol. 2019 May;70(5):1033. doi: 10.1016/j.jhep.2019.01.023. Epub 2019 Feb 19. J Hepatol. 2019. PMID: 30795934 No abstract available.
Similar articles
-
Occult liver disease: A multinational perspective.Ann Hepatol. 2024 May-Jun;29(3):101480. doi: 10.1016/j.aohep.2024.101480. Epub 2024 Feb 12. Ann Hepatol. 2024. PMID: 38354950
-
Measuring the global burden of disease and epidemiological transitions: 2002-2030.Ann Trop Med Parasitol. 2006 Jul-Sep;100(5-6):481-99. doi: 10.1179/136485906X97417. Ann Trop Med Parasitol. 2006. PMID: 16899150 Review.
-
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.MMWR Suppl. 2014 Oct 31;63(4):3-27. MMWR Suppl. 2014. PMID: 25356673
-
Characterization of Deaths from Cirrhosis of the Liver in Cuba, 1987-2017.MEDICC Rev. 2020 Oct;22(4):35-39. doi: 10.37757/MR2020.V22.N4.6. MEDICC Rev. 2020. PMID: 33295318
-
Current and Future Burden of Chronic Nonmalignant Liver Disease.Clin Gastroenterol Hepatol. 2015 Nov;13(12):2031-41. doi: 10.1016/j.cgh.2015.08.015. Epub 2015 Aug 17. Clin Gastroenterol Hepatol. 2015. PMID: 26291665 Free PMC article. Review.
Cited by
-
A radiomics-based model to classify the etiology of liver cirrhosis using gadoxetic acid-enhanced MRI.Sci Rep. 2021 May 24;11(1):10778. doi: 10.1038/s41598-021-90257-9. Sci Rep. 2021. PMID: 34031487 Free PMC article.
-
MRI-based radiomic feature analysis of end-stage liver disease for severity stratification.Int J Comput Assist Radiol Surg. 2021 Mar;16(3):457-466. doi: 10.1007/s11548-020-02295-9. Epub 2021 Mar 1. Int J Comput Assist Radiol Surg. 2021. PMID: 33646521 Free PMC article.
-
Insights from qualitative research on NAFLD awareness with a cohort of T2DM patients: time to go public with insulin resistance?BMC Public Health. 2020 Jul 20;20(1):1142. doi: 10.1186/s12889-020-09249-5. BMC Public Health. 2020. PMID: 32690054 Free PMC article.
-
Cellular plasticity balances the metabolic and proliferation dynamics of a regenerating liver.Genome Res. 2021 Apr;31(4):576-591. doi: 10.1101/gr.267013.120. Epub 2021 Mar 1. Genome Res. 2021. PMID: 33649154 Free PMC article.
-
Yi-Qi-Jian-Pi Formula Suppresses RIPK1/RIPK3-Complex-Dependent Necroptosis of Hepatocytes Through ROS Signaling and Attenuates Liver Injury in Vivo and in Vitro.Front Pharmacol. 2021 Apr 23;12:658811. doi: 10.3389/fphar.2021.658811. eCollection 2021. Front Pharmacol. 2021. PMID: 33967802 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous